Kiran Mazumdar-Shaw Explains Biocon's Q2 Performance

Kiran Mazumdar-Shaw, chairman and managing director at Biocon, said its net profit rose over 200 per cent to Rs 306 crore for the July-September quarter supported by one-time gains from Syngene's share sale.

Related Videos